NewAmsterdam Pharma (NAMS) Net Equity Issued and Repurchased (2023 - 2026)
NewAmsterdam Pharma (NAMS) posted Net Equity Issued and Repurchased of $10.89 million for Q2 2026, up 218.2% from $3.42 million a year earlier and up 4.6% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at NewAmsterdam Pharma was $39.43 million, up 237.4% year-over-year; for FY2025, it came in at $29.47 million, up 114.1% from FY2024.
- Annual Net Equity Issued and Repurchased shows a four-year compound annual growth rate of -23.2% (FY2021 to FY2025).
- In prior years, NewAmsterdam Pharma's Net Equity Issued and Repurchased was $13.76 million in FY2024 (+59.6%), $8.62 million in FY2023 (-96.3%), $234.6 million in FY2022 (+177.0%) and $84.7 million in FY2021.
- Quarterly Net Equity Issued and Repurchased has run from a low of $1,000 in Q3 2023 to a high of $12.5 million in Q4 2025 over five years.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in two of the last four quarters, with growth averaging 53.4%.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $10.41 million (Q1 2026), $12.5 million (Q4 2025) and $5.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | NewAmsterdam Pharma | 2.86 Bn | 2.86 Bn | - | 10.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.89 Mn |
| Mar 31, 2026 | 10.41 Mn |
| Dec 31, 2025 | 12.50 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Jun 30, 2025 | 3.42 Mn |
| Mar 31, 2025 | 7.92 Mn |
| Dec 31, 2024 | 340,000.00 |
| Jun 30, 2024 | 4.66 Mn |
| Mar 31, 2024 | 8.76 Mn |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 6.23 Mn |
| Mar 31, 2023 | 2.39 Mn |
API Access
NewAmsterdam Pharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();